As many as one in three COVID-19 survivors experience a mental health or neurological disorder, adding to a growing body of evidence that show COVID-19 can have serious and potentially long-lasting effects on the brain. The Penn Neuro COVID Clinic aims to assess and treat long-haul COVID patients suffering from neurological symptoms.
A new study from Washington University School of Medicine in St. Louis shows that even mild cases of COVID-19 increase the risk of death in the six months following diagnosis and that this risk increases with disease severity. The comprehensive study also catalogues the wide-ranging and long-term health problems often triggered by the infection, even among those not hospitalized.
UC San Diego clinical trial suggests ivabradine may be effective in treating postural orthostatic tachycardia syndrome, a potential COVID-19 long-hauler symptom.
Jefferson researchers join a CDC study to follow COVID-19 “long-haulers” and their symptoms.
People who have recovered from coronavirus can make potent antibodies to SARS-CoV-2 that evolve in the months after infection. These antibodies may be evolving in response to residual viral antigen hidden in the gut.